» Authors » Riccardo Schiavina

Riccardo Schiavina

Explore the profile of Riccardo Schiavina including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 323
Citations 3387
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Falkenbach F, Penaranda N, Longoni M, Marmiroli A, Le Q, Catanzaro C, et al.
Int J Urol . 2025 Mar; PMID: 40084789
Objective: Radical prostatectomy (RP) may be a treatment option for prostate cancer in patients with chronic kidney disease (CKD). However, the effect of CKD on adverse in-hospital outcomes after RP...
2.
Falkenbach F, Penaranda N, Longoni M, Marmiroli A, Le Q, Catanzaro C, et al.
Urol Oncol . 2025 Mar; PMID: 40059014
Introduction: Radical prostatectomy (RP) may be a treatment option for prostate cancer patients with cirrhosis and liver disease (CLD). However, the effect of CLD on adverse in-hospital outcomes after RP...
3.
Longoni M, Penaranda N, Marmiroli A, Falkenbach F, Le Q, Nicolazzini M, et al.
Urology . 2025 Mar; PMID: 40057122
Objective: To investigate whether bimodal therapy (BMT) or trimodal therapy (TMT) differ from radical cystectomy (RC) + perioperative chemotherapy (CT) in cancer control outcomes among patients with non-organ-confined (NOC; T3-4...
4.
Nicolazzini M, Penaranda N, Falkenbach F, Longoni M, Marmiroli A, Le Q, et al.
World J Urol . 2025 Mar; 43(1):149. PMID: 40044881
Purpose: Chronic kidney disease (CKD) is frequent in bladder cancer patients undergoing radical cystectomy (RC) with ileal conduit. However, the effect of CKD on adverse in-hospital outcomes after ileal conduit...
5.
de Barros H, Downes M, Droghetti M, Bekers E, Giunchi F, Brunocilla E, et al.
Urology . 2025 Feb; PMID: 39922236
Objective: To evaluate the occurrence and the oncological predictive value of cribriform growth and/or intraductal carcinoma (CR/IDC) in patients with ISUP grade group (GG) 2 prostate cancer (PCa) at radical...
6.
Carbonara U, Ditonno F, Beksac A, Derweesh I, Cerrato C, Celia A, et al.
Int Braz J Urol . 2025 Feb; 51(2). PMID: 39913094
Background: Different modalities of percutaneous thermal ablation (PTA) have been used as possible minimally invasive nephron-sparing treatments for small renal masses (SRMs). The present study aimed to compare long-term outcomes...
7.
Gandaglia G, Barletta F, Scuderi S, Scilipoti P, Rajwa P, Huebner N, et al.
Eur Urol Oncol . 2025 Jan; PMID: 39890547
Background And Objective: Extended pelvic lymph node dissection (ePLND) is recommended in selected radical prostatectomy (RP) prostate cancer (PCa) patients for staging purposes. We aim to externally validate available tools...
8.
Tassinari E, Danielli L, Marchetti A, Rosellini M, Ricci C, Piazza P, et al.
Hum Vaccin Immunother . 2024 Dec; 21(1):2440165. PMID: 39701156
In recent years, several clinical trials focused on the potential role of immune-checkpoint inhibitors (ICIs) in the adjuvant treatment of muscle-invasive urothelial cancer (UC). Heretofore, only the anti-programmed death protein...
9.
Cochetti G, Del Zingaro M, Maiolino G, Paladini A, Mearini M, Schiavina R, et al.
Basic Clin Androl . 2024 Dec; 34(1):24. PMID: 39617887
Background: Despite numerous efforts to demonstrate the presence of the SARS-CoV-2 in semen of affected males, no clear evidence exists. We conducted a multicenter prospective study on adult patients with...
10.
Tamburini S, Bianchi L, Piazza P, Mottaran A, Ercolino A, Rotaru V, et al.
Urologia . 2024 Nov; 92(1):67-74. PMID: 39540262
Background: Thanks to the improved accuracy of multiparametric Magnetic Resonance Imaging (mpMRI) to detect and localize the dominant index lesion on prostate cancer (PCa), the concept of minimally invasive focal...